Ángel Carracedo, Graduate (1978) and Doctor (1982) in Medicine at the University of Santiago (USC), both with honors, has created a group that has become a world leader in forensic genetics and a reference in comparative genomics and population. He is a pioneer in the introduction of new technologies for forensic identification by molecular genetic techniques which have been implemented in laboratories around the world. He has participated, along with collaborator, in more than three thousand forensic examinations worldwide. Carracedo is Full Professor of Legal Medicine at the USC, but has become the Leonardo Da Vinci of genetics at the Genomic Medicine group, consisting of about ninety people from at least ten countries. In the field of clinical oncology he has opened new avenues for identifying genes of colon, breast and thyroid cancer, and in genetic disorders for the detection of the molecular basis of schizophrenia or postpartum depression. In the field of Neurogenetics he is working on finding mutations related to Alzheimer's or identifying the molecular mechanisms associated with migraine or rare diseases such as ataxia or Charcott-Marie-Tooh’s disease, whereas in the cardiovascular area he draws attention to the study of genetic variations associated with sudden cardiac death or genetic diagnosis of hypertrophic myocard. Angel Carracedo, who is also director of the main node of the National Center of Genotyping, based in Santiago, has devoted special attention in recent years in pharmacogenetics. His professional career is reflected in the publication of research articles in journals of highest scientific impact. He has published over 340 articles on genomic medicine, clinical genetics and forensic genetics and populations. He is also editor of the "Forensic Science International: Genetics" magazine and member of fifteen international genetics and forensics magazines.